Comparing the two leading erythroid lines BEL-A and HUDEP-2
Haematologica
.
2020 Aug;105(8):e389-e394.
doi: 10.3324/haematol.2019.229211.
Epub 2019 Nov 21.
Authors
Deborah E Daniels
1
2
,
Damien J Downes
3
,
Ivan Ferrer-Vicens
1
,
Daniel C J Ferguson
1
,
Belinda K Singleton
2
4
,
Marieangela C Wilson
1
,
Kongtana Trakarnsanga
5
,
Ryo Kurita
6
,
Yukio Nakamura
7
,
David J Anstee
2
4
,
Jan Frayne
8
2
Affiliations
1
School of Biochemistry, University of Bristol, Bristol, UK.
2
NIHR Blood and Transplant Research Unit, University of Bristol, Bristol, UK.
3
MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
4
Bristol Institute for Transfusion Sciences, National Health Service Blood and Transplant (NHSBT), Bristol, UK.
5
Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
6
Department of Research and Development, Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
7
Cell Engineering Division, RIKEN BioResource Research Center, Ibaraki, Japan.
8
School of Biochemistry, University of Bristol, Bristol, UK jan.frayne@bristol.ac.uk.
PMID:
31753923
PMCID:
PMC7395286
DOI:
10.3324/haematol.2019.229211
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Cell Line, Tumor
Humans
Liver Neoplasms*
Grants and funding
MR/S021140/1/MRC_/Medical Research Council/United Kingdom
106130/Z/14/Z/WT_/Wellcome Trust/United Kingdom
MR/R009341/1/MRC_/Medical Research Council/United Kingdom
WT_/Wellcome Trust/United Kingdom
IS-BTU-1214-10032/DH_/Department of Health/United Kingdom
MR/T014067/1/MRC_/Medical Research Council/United Kingdom